Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
ID: 355353Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/355353

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PA-24-253.html
Timeline
    Description

    The National Institutes of Health (NIH) has announced a funding opportunity titled "Successor-in-Interest (Type 6 Parent Clinical Trial Optional)," allowing organizations holding specific NIH grants to apply for a change of recipient organization status. Eligible applicants include a diverse range of entities such as higher education institutions, non-profits, for-profit organizations, and government entities, provided they maintain the original project's research scope and comply with NIH policies. This opportunity is crucial for organizations seeking to continue research efforts under new management while adhering to established guidelines, with applications accepted from July 19, 2024, until July 18, 2027. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov, and detailed information can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PA-24-253.html.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PA-24-253.html
    The Department of Health and Human Services, through the National Institutes of Health (NIH), has announced a funding opportunity titled "Successor-in-Interest (Type 6 Parent Clinical Trial Optional)." This opportunity allows organizations holding certain NIH grants to submit applications for a change of recipient organization status, often referred to as Successor-in-Interest. Eligible applicants include higher education institutions, non-profits, for-profit organizations, and government entities. The new organization must maintain the original project's research scope and comply with all NIH policies. Applications must specify whether they are for single or multi-project activity codes, with specific submission guidelines for each. The document also outlines necessary registrations, application submission processes, and budget limitations tied to direct costs previously associated with the original recipient. Although applications undergo an administrative evaluation instead of peer review, adherence to human subjects protections and inclusion principles are crucial. The announced funding opportunity opens for submissions on July 19, 2024, and permits funding requests up until July 18, 2027.
    Similar Opportunities
    Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) for organizations seeking to change the recipient organization of specific NIH grants. This initiative allows eligible applicants, including higher education institutions, nonprofits, and various government entities, to submit applications for the transfer of grant awards, ensuring continuity in research projects. While the submission of applications does not guarantee approval for the transfer, the NIH encourages coordination with relevant institutes and adherence to grant policies to facilitate a smooth transition. Interested parties can find more information and submit inquiries via email at grantsinfo@nih.gov, with key submission dates starting from July 12, 2024, and the opportunity closing on July 12, 2027.
    Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for competing revisions to existing Single Project Research Grants and Cooperative Agreements, with the option for clinical trials. This initiative allows NIH award recipients to apply for additional funds to expand their current projects within the relevant Institutes and Centers, specifically in response to Notices of Special Interest (NOSI) issued by participating NIH entities. The funding opportunity, identified as PA-23-317, is open to a wide range of eligible applicants, including higher education institutions, nonprofit organizations, and foreign entities, reflecting NIH's commitment to advancing impactful health research. Applications must be submitted by November 24, 2026, through the NIH ASSIST system or Grants.gov, and will be evaluated based on scientific merit and adherence to specified criteria. For further information, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) to support discrete scientific projects aligned with the interests of various NIH Institutes and Centers. This grant is specifically designed for projects that do not involve clinical trials, focusing instead on advancing health-related research and development. Eligible applicants include a wide range of organizations such as higher education institutions, nonprofits, and tribal governments, with no fixed budget limits, although applicants must justify their requested funding. Interested parties should note that the application deadline is January 7, 2025, and can find more information by contacting the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV or visiting the official announcement at http://grants.nih.gov/grants/guide/pa-files/PA-20-185.html.
    NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Pathway to Independence Award (K99/R00), a federal grant aimed at facilitating the transition of postdoctoral researchers into independent faculty positions. This program provides up to five years of support through two phases: the K99 phase offers up to two years of mentored training and research, while the R00 phase provides up to three years of independent research funding, contingent upon satisfactory progress and appointment to a qualifying faculty position. The initiative emphasizes the development of a diverse pool of skilled scientists and requires applicants to propose a significant research plan, establish a solid mentorship framework, and demonstrate institutional commitment to their career development. Interested applicants must submit their proposals by May 7, 2027, and can find additional information at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Small Business Transition Grant for New Entrepreneurs (R41/R42 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the "Small Business Transition Grant for New Entrepreneurs (R41/R42 Clinical Trial Not Allowed)" to support early-career scientists in their transition to entrepreneurship. This grant aims to facilitate the development of small business concerns (SBCs) by employing researchers as Program Directors/Principal Investigators (PDs/PIs), providing them with essential entrepreneurial training, mentorship, and a structured framework for developing commercially viable biomedical technologies. The program is particularly focused on enhancing the entrepreneurial skills of scientists with strong technical expertise but limited experience in entrepreneurship, thereby aligning with NIH's mission to improve health. Interested applicants must be U.S.-based small businesses, and the application process will commence in September 2024, with a closing date of April 5, 2027. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-24-133.html.
    Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Not Allowed) to support early-career scientists transitioning into entrepreneurship. This funding opportunity aims to facilitate the development of promising technologies by small business concerns (SBCs) while providing mentorship and entrepreneurial training for Program Directors/Principal Investigators (PDs/PIs) who are new to research entrepreneurship. The initiative is designed to enhance the biomedical workforce by coupling scientific expertise with essential business skills, ultimately contributing to public health advancements. Applications are invited for SBIR Phase I and Fast-Track grants, with deadlines ranging from September 2024 to April 2027. For more information, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-24-131.html.
    Research Project Grant (Parent R01 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a Research Project Grant (Parent R01 Clinical Trial Required) to support specified clinical research projects that align with the missions of various NIH institutes. Applicants are required to propose at least one clinical trial, focusing on significant health-related research areas, and must comply with the NIH Grants Policy Statement. This funding opportunity is crucial for advancing medical science and improving patient care, emphasizing innovation and scientific merit in addressing important health issues. The application deadline is January 7, 2025, and interested parties can reach out to the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV for further inquiries. More details can be found at the provided link: http://grants.nih.gov/grants/guide/pa-files/PA-20-183.html.
    Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for the Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required), inviting applications for long-term clinical trials lasting 6 or 7 years. These trials must be hypothesis-driven, aligned with NIH's research mission, and include clearly defined objectives and milestone planning to monitor progress. This initiative emphasizes the importance of extended clinical trials in advancing critical biomedical research, with no specific budget limits but requiring justification based on project needs. Interested applicants must consult with NIH staff prior to submission, adhere to new application forms and data sharing policies, and submit their applications by January 13, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-23-084.html.
    NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Pathway to Independence Award (K99/R00), a federal grant aimed at supporting postdoctoral researchers in their transition to independent faculty positions. This program is designed to provide up to five years of funding, divided into two phases: the K99 phase for mentored training and the R00 phase for independent research, specifically targeting individuals with no more than four years of postdoctoral experience. The initiative emphasizes the importance of cultivating a diverse and skilled workforce in biomedical and clinical research, encouraging applications from underrepresented groups. Interested applicants must submit their proposals by May 7, 2027, and can find additional information and application guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    Small Business Transition Grant for New Entrepreneurs (R41/R42 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Small Business Transition Grant for New Entrepreneurs (R41/R42 Clinical Trial Required) to support early-career scientists transitioning into entrepreneurial roles within small businesses. This funding opportunity aims to facilitate the career development of investigators by providing entrepreneurial training, mentorship, and support for research and development projects that align with NIH's mission to improve health. Eligible small business concerns (SBCs) can apply for Phase I and Fast-Track grants, with funding amounts typically reaching $306,872 for Phase I and $2,045,816 for Phase II awards. Applications will be accepted starting August 5, 2024, with a closing date of April 5, 2027. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-24-134.html.